Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133903) titled 'Study on the Extended Treatment of IgA Nephropathy with Budesonide Enteric-Coated Capsules' on Oct. 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

Condition: IgA nephropathy

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-10-31

Target Sample Size: Budesonide Enteric Capsules Treatment Group:125;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=344829

Disclaimer: Curated by HT Syndication....